Comprehensive Biotechnological Strategies for Podophyllotoxin Production from Plant and Microbial Sources

Abstract

Podophyllotoxin is derived from plant sources and exhibits strong anticancer activity. However, limited natural availability and environmental impacts from traditional extraction methods drive the search for alternative production approaches. This review explores diverse strategies for sustainable podophyllotoxin synthesis, including biosynthesis, semi-synthesis, and biotransformation. Biosynthetic methods involve metabolic pathway engineering in plant or microbial cells, enabling increased yields by manipulating precursor availability and gene expression. Semi-synthetic approaches modify podophyllotoxin precursors or intermediates to enhance therapeutic effects, with derivatives like etoposide and teniposide showing clinical efficacy. Biotransformation, utilising organisms such as endophytic fungi or human hepatic enzymes, enables the transformation of substrates like deoxypodophyllotoxin into podophyllotoxin or its derivatives, yielding compounds with reduced environmental impact and improved purity. The anticancer efficacy of podophyllotoxin and its derivatives stems from multiple mechanisms. These compounds disrupt cell mitosis by inhibiting microtubule assembly, impairing nucleoside transport, and blocking topoisomerase II activity, leading to DNA cleavage and cancer cell apoptosis. Podophyllotoxin and its derivatives also exhibit anti-angiogenesis and anti-metastatic effects through signalling pathway modulation. Notably, derivatives like deoxypodophyllotoxin utilise advanced delivery systems, enhancing targeted efficacy and reducing side effects. Given the varied mechanisms and growing therapeutic applications, optimising biotransformation and delivery techniques remains essential for advancing podophyllotoxin-based therapies. This comprehensive review underscores the compoundʼs potential as a robust anticancer agent and the need for continued research to maximise its production and clinical effectiveness.

Keywords

podophyllotoxin - Podophyllum hexandrum - Berberidaceae - natural product - endophytic fungi - bioproduction

Publication History

Received: 12 June 2024

Accepted after revision: 16 December 2024

Accepted Manuscript online:
17 December 2024

Article published online:
20 January 2025

• References

• 1 Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites 2012; 2: 303-336
• 2 Vasundhara M, Kumar A, Reddy MS. Molecular approaches to screen bioactive compounds from endophytic fungi. Front Microbiol 2016; 7: 1774
• 3 Jalgaonwala RE, Mohite BV, Mahajan RT. A review: Natural products from plant associated endophytic fungi. J Microbiol Biotech Res 2011; 1: 21-32
• 4 Xia Y, Liu L, Chen C, Mo X, Tan Q, He Y, Wang Z, Yin J, Zhou G. The multifunctions and future prospects of endophytes and their metabolites in plant disease management. Microorganisms 2022; 10: 1072
• 5 Zhao J, Zhou L, Wang J, Shan T, Zhong L, Liu X, Gao L. Endophytic fungi for producing bioactive compounds originally from their host plants. In: Mendez-Vilas A, editor. Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology Seville: Formatex Research Center, Spain; 2010. 1. 567-576
• 6 Guerram M, Jiang ZZ, Zhang LY. Podophyllotoxin, a medicinal agent of plant origin: Past, present and future. Chin J Nat Med 2012; 10: 161-169
• 7 Gordaliza M, García PA, Miguel Del Corral JM, Castro MA, Gómez-Zurita MA. Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives. Toxicon 2004; 44: 441-459
• 8 Liu YQ, Yang L, Tian X. Podophyllotoxin: Current perspectives. Curr Bioact Compd 2007; 3: 37-66
• 9 Mukherjee A, Basu S, Sarkar N, Ghosh A. Advances in cancer therapy with plant based natural products. Curr Med Chem 2012; 8: 1467-1486
• 10 Botta B, Monache G, Misiti D, Vitali A, Zappia G. Aryltetralin lignans: Chemistry, pharmacology and biotransformations. Curr Med Chem 2001; 8: 1363-1381
• 11 Chaurasia O, Ballabh B, Tayade A, Kumar R, Kumar G, Singh S. Podophyllum L.: An endergered and anticancerous medicinal plant─An overview. Indian J Tradit Knowl 2012; 11: 234-241
• 12 Podwyssotzki V. Pharmakologische Studien über Podophyllum peltatum . Arch Exp Pathol Pharmakol 1880; 13: 29-52
• 13 Kaplan IW. Condylomata acuminata. New Orleans Med Surg J 1942; 94: 388-390
• 14 Motyka S, Jafernik K, Ekiert H, Sharifi-Rad J, Calina D, Al-Omari B, Szopa A, Cho WC. Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy. Biomed Pharmacother 2023; 158: 114-145
• 15 Long BH, Brattain MG. The activity of etoposide and teniposide against human lung tumour in vitro: Cytotoxicity and DNA breakage. In: Issell BF, Muggia FM, Carter SK. editors Etoposide: Current Status and New Developments. New York: Acad Press NY; 1984: 223
• 16 Long BH, Minocha A. Inhibition of topoisomerase II by VP-16 (etoposide), VM-26 (teniposide) and structure congeners as explanation for in vivo DNA breakage and cytotoxicitry. Proc Am Cancer Res 1983; 24: 1271
• 17 Shah Z, Gohar UF, Jamshed I, Mushtaq A, Mukhtar H, Zia-UI-Haq M, Toma SI, Manea R, Moga M, Popovici B. Podophyllotoxin: History, recent advances and future prospects. Biomolecules 2021; 11: 603
• 18 Pingaew R, Mandi P, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1, 2, 3, 4-tetrahydroisoquinoline-based triazoles with potential anticancer activity. Eur J Med Chem 2014; 81: 192-203
• 19 Xiao L, Zhao W, Li HM, Wan DJ, Li DS, Chen T, Tang YJ. Design and synthesis of the novel DNA topoisomerase II inhibitors: Esterification and amination substituted 4′-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways. Eur J Med Chem 2014; 80: 267-277
• 20 Găman AM, Egbuna C, Găman MA. Natural bioactive lead compounds effective against haematological malignancies. In: Egbuna C, Kumar S, Ifemeje JC, Ezzat SM, Kaliyaperumal S, editors Phytochemicals as Lead Compounds for New Drug Discovery. Elsevier; 2019: 95-115
• 21 Kamal A, Ali Hussaini SM, Rahim A, Riyaz S. Podophyllotoxin derivatives: A patent review (2012–2014). Expert Opin Ther Pat 2015; 25: 1025-1034
• 22 Sloan JM. A phase II single-center, randomized, open-label, safety and efficacy study of etoposide in patients with COVID-19 infection. Accessed 11th December, 2021 at: http://clinicaltrials.gov/study/NCT04356690
• 23 Miranda-Vera C, Hernández ÁP, García-García P, Díez D, García PA, Castro MÁ. Podophyllotoxin: Recent advances in the development of hybridization strategies to enhance its moral profile. Pharmaceutics 2023; 15: 2728
• 24 Zhang C, Zuo Y, Zhang T, Zhang X, Ling J, Liu C, Chen H, Zhou X, Wang M, Deng Y, Liu Y, Lu J. Advances in nanoscale carrier-based approaches to reduce toxicity and enhance efficacy of podophyllotoxin. Acta Materia Medica 2023; 2: 4
• 25 Cortese F, Bhattacharyya B, Wolff J. Podophyllotoxin as a probe for the colchicine binding site of tubulin. J Biol Chem 1977; 252: 1134-1140
• 26 Han HW, Lin HY, He DL, Ren Y, Sun WX, Liang L, Du MH, Li DC, Chu YC, Wang XM, Yang YH. Novel podophyllotoxin derivatives as potential tubulin inhibitors: Design, synthesis, and antiproliferative activity evaluation. Chem Biodivers 2018; 15: e1800289
• 27 Kamal A, Suresh P, Mallareddy A, Kumar BA, Reddy PV, Raju P, Tamboli JR, Shaik TB, Jain N, Kalivendi SV. Synthesis of a new 4-aza-2, 3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents. Bioorg Med Chem 2011; 19: 2349-2358
• 28 Kandil S, Wymant JM, Kariuki BM, Jones AT, McGuigan C, Westwell AD. Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells. Eur J Med Chem 2016; 110: 311-325
• 29 Hyder I, Yedlapudi D, Kalivendi SV, Khazir J, Ismail T, Nalla N, Miryala S, Kumar HMS. Synthesis and biological evaluation of novel 4β-[(5-substituted)-1, 2, 3, 4-tetrazolyl] podophyllotoxins as anticancer compounds. Bioorg Med Chem Lett 2015; 25: 2860-2863
• 30 Sadeghi I, Behmanesh M, Ahmadian Chashmi N, Sharifi M, Soltani BM. 6-methoxy podophyllotoxin induces apoptosis via inhibition of TUBB3 and TOPIIA gene expressions in 5637 and K562 cancer cell lines. Cell J 2015; 17: 502-509
• 31 Bai JK, Zhao W, Li HM, Tang YJ. Novel biotransformation process of podophyllotoxin to 4 -Sulfur-substituted podophyllum derivates with anti-tumor activity by Penicillium purpurogenum Y.J. Tang. Curr Med Chem 2012; 19: 927-936
• 32 Zhao W, Bai JK, Li HM, Chen T, Tang YJ. Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity. Sci Rep 2015; 5: 10172
• 33 Zhao W, He L, Xiang TL, Tang YJ. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain. Eur J Med Chem 2019; 170: 73-86
• 34 Evans WK, Osoba D, Feld R, Shepherd FA, Bazos MJ, DeBoer G. Etoposide (VP-16) and cisplatin: An effective treatment for relapse in small-cell lung cancer. J Clin Oncol 1985; 3: 65-71
• 35 Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW. CASPIAN investigators. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): A randomised, controlled, open-label, phase 3 trial. The Lancet 2019; 394: 1929-1939
• 36 Kinner A, Wu W, Staudt C, Iliakis G. γ-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 2008; 36: 5678-5694
• 37 Stähelin HF, von Wartburg A. The chemical and biological route from podophyllotoxin glucoside to etoposide: Ninth Cain Memorial Award lecture. Cancer Res 1991; 51: 5-15
• 38 Shankaraiah N, Kumar NP, Amula SB, Nekkanti S, Jeengar MK, Naidu VGM, Reddy TS, Kamal A. One-pot synthesis of podophyllotoxin–thiourea congeners by employing NH2SO3H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents. Bioorg Med Chem Lett 2015; 25: 4239-4244
• 39 Reddy VG, Bonam SR, Reddy TS, Akunuri R, Naidu VGM, Nayak VL, Bhargava SK, Kumar HMS, Srihari P, Kamal A. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer. Eur J Med Chem 2018; 144: 595-611
• 40 Sathish M, Kavitha B, Nayak VL, Tangella Y, Ajitha A, Nekkanti S, Alarifi A, Shankaraiah N, Nagesh N, Kamal A. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors. Eur J Med Chem 2018; 144: 557-571
• 41 Chen H, Wang J, Zhang J, Wang Y, Cao B, Bai S, Yu PF, Bi W, Xie W. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line. Biol Pharm Bull 2009; 32: 609-613
• 42 Chen H, Bi W, Cao B, Yang Z, Chen S, Shang H, Yu P, Yang J. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200. Eur J Pharmacol 2010; 627: 69-74
• 43 Tailor D, Going CC, Resendez A, Kumar V, Nambiar DK, Li Y, Dheeraj A, LaGory EL, Ghoochani A, Birk AM, Stoyanova T, Ye J, Giaccia AJ, Le QT, Singh RP, Sledge GW, Pitteri SJ, Malhotra SV. Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer. Br J Cancer 2021; 124: 604-615
• 44 Nayak D, Kumar A, Chakraborty S, Rasool RU, Amin H, Katoch A, Gopinath V, Mahajan V, Zilla MK, Rah B, Gandhi SG, Ali A, Kumar LD, Goswami A. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p 53-defective cancer cells. Cell Death Differ 2017; 24: 1275-1287
• 45 Katoch A, Nayak D, Faheem MM, Kumar A, Sahu PK, Gupta AP, Kumar LD, Goswami A. Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2. Cell Death Discov 2021; 7: 1-13
• 46 Li Y, Huang T, Fu Y, Wang T, Zhao T, Guo S, Sun Y, Yang Y, Li C. Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway. PLOS ONE 2019; 14: e0215886
• 47 Li Y, Wang T, Sun Y, Huang T, Li C, Fu Y, Li Y, Li C. p 53-mediated PI3K/AKT/mTOR pathway played a role in Ptox^Dpt-induced EMT inhibition in liver cancer cell lines. Oxid Med Cell Longev 2019; 2019: e2531493
• 48 Sang CY, Xu XH, Qin WW, Liu JF, Hui L, Chen SW. DPMA, a deoxypodophyllotoxin derivative, induces apoptosis and anti-angiogenesis in non-small cell lung cancer A549 cells. Bioorg Med Chem Lett 2013; 23: 6650-6655
• 49 Kamal A, Tamboli JR, Ramaiah MJ, Adil SF, Pushpavalli SNCVL, Ganesh R, Sarma P, Bhadra U, Pal-Bhadra M. Quinazolino linked 4β-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation. Bioorg Med Chem 2013; 21: 6414-6426
• 50 Ren J, Liu Y, Li L, Zhao Y, Li Z, Wu C, Chen L, Hu K. OAMDP, a novel podophyllotoxin derivative, induces apoptosis, cell cycle arrest and autophagy in hepatoma HepG2 cells. Cell Biol Int 2018; 42: 194-204
• 51 Yang YJ, Qi SN, Shi RY, Yao J, Wang LS, Yuan HQ, Jing YX. Induction of apoptotic DNA fragmentation mediated by mitochondrial pathway with caspase-3-dependent BID cleavage in human gastric cancer cells by a new nitroxyl spin-labeled derivative of podophyllotoxin. Biomed Pharmacother 2017; 90: 131-138
• 52 Han HW, Qiu HY, Hu C, Sun WX, Yang RW, Qi JL, Wang XM, Lu GH, Yang YH. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs. Bioorg Med Chem Lett 2016; 26: 3237-3242
• 53 Yong P, Si-Bao C, Yong L, Shi-Lin C, Pei-Gen X. A pharmacophylogenetic study of the Berberidaceae (s.l.). J Syst Evol 2006; 44: 241
• 54 Liu J, Chen Z, Lu A. Molecular evidence for the sister relationship of the eastern Asia-North American intercontinental species pair in the Podophyllum group (Berberidaceae). Bot Bull Acad Sin 2002; 43: 147-154
• 55 Nag A, Ahuja PS, Sharma RK. Genetic diversity of high-elevation populations of an endangered medicinal plant. AoB PLANTS 2015; 7: plu076
• 56 Kumari A, Singh D, Kumar S. Biotechnological interventions for harnessing podophyllotoxin from plant and fungal species: current status, challenges, and opportunities for its commercialization. Crit Rev Biotechnol 2017; 37: 739-753
• 57 Jackson DE, Dewick PM. Tumour-inhibitory aryltetralin lignans from Podophyllum pleianthum . Phytochemistry 1985; 24: 2407-2409
• 58 Yin ML, Chen ZL. Chemical constituents of Dysosma aurantiocaulis (H.-M.) Hu and Dysosma pleianthum Woods. Zhongguo Zhong Yao Za Zhi – China J Chin Mater Medica 1989; 14: 420-447
• 59 van Uden W, Pras N, Maingré TM. The accumulation of podophyllotoxin-β-D-glucoside by cell suspension cultures derived from the conifer Callitris drummondii . Plant Cell Rep 1990; 9: 257-260
• 60 Broomhead AJ, Dewick PM. Tumour-inhibitory aryltetralin lignans in Podophyllum versipelle, Diphylleia cymosa and Diphylleia grayi . Phytochemistry 1990; 29: 3831-3837
• 61 Yu PZ, Wang LP, Chen ZN. A new podophyllotoxin-type lignan from Dysosma versipellis var. tomentosa . J Nat Prod 1991; 54: 1422-1424
• 62 Ma C, Yang JS, Luo SR. Study on lignans from Diphylleia sinensis . Yao Xue Xue Bao – Acta Pharm Sin 1993; 28: 690-694
• 63 Kuhnt M, Rimpler H, Heinrich M. Lignans and other compounds from the mixe indian medicinal plant Hyptis verticillata . Phytochemistry 1994; 36: 485-489
• 64 Konuklugil B. Investigation of podophyllotoxin in some plants in lamiaceae using HPLC: Türkiyeʼde yetişen lamiaceae familyasindaki bazi türlerde podofilotoksinʼin yüksek basinçli sivi kromatografisi ile tespiti. Ank Univ Eczacilik Fak Derg 1996; 1: 23-27
• 65 Muranaka T, Miyata M, Ito K, Tachibana S. Production of podophyllotoxin in Juniperus Chinensis callus cultures treated with oligosaccharides and a biogenetic precursor in honour of Professor G. H. Neil Towers 75th birthday. Phytochemistry 1998; 2: 491-496
• 66 Udino L, Abaul J, Bourgeois P, Gorrichon L, Duran H, Zedde C. Lignans from the seeds of Hernandia sonora . Planta Med 1999; 65: 279-281
• 67 Zhang M, Shi D. Determination of podophyllotoxin lignans in Dysosma and its allied plants. Zhong Yao Cai – J Chin Med Mater 2001; 24: 411-413
• 68 Bedir E, Khan I, Moraes RM. Bioprospecting for podophyllotoxin. In: J Janick, A Whipkey. editors Trends in New Crops and New Uses. Alexandria: ASHS Press; 2002: 545-549
• 69 Mohagheghzadeh A, Gholami A, Soltani M, Hemmati S, Alfermann W. Linum mucronatum: Organ to organ lignan variations. Z Naturforsch C J Biosci 2005; 60: 508-510
• 70 Lautié E, Villarreal ML, Fliniaux MA. Hyptis suaveolens, an alternative source of podophyllotoxin?. Planta Med 2008; 74: PC83
• 71 Zhao YP, Gong HD, Lu WQ, Jiang WM, Zhou XL, Fu CX. Growth, photosynthesis and podophyllotoxin accumulation of Dysosma versipellis in response to a light gradient and conservation implications. Chin Sci Bull 2011; 56: 2570-2575
• 72 Kusari S, Zühlke S, Spiteller M. Chemometric evaluation of the anti‐cancer pro‐drug podophyllotoxin and potential therapeutic analogues in Juniperus and Podophyllum species. Phytochem Anal 2011; 22: 128-143
• 73 Renouard S, Lopez T, Hendrawati O, Dupre P, Doussot J, Falguieres A, Ferroud C, Hagege D, Lamblin F, Laine E, Hano C. Podophyllotoxin and deoxypodophyllotoxin in Juniperus bermudiana and 12 other Juniperus species: Optimization of extraction, method validation, and quantification. J Agric Food Chem 2011; 59: 8101-8107
• 74 Zheljazkov VD, Cantrell CL, Donega MA, Astatkie T. Bioprospecting for podophyllotoxin in the Big Horn Mountains, Wyoming. Ind Crops Prod 2013; 43: 787-790
• 75 Paul S, Nandi SK, Palni LMS. Assessment of genetic diversity and interspecific relationships among three species of Podophyllum using AFLP markers and podophyllotoxin content. Plant Syst Evol 2013; 299: 1879-1887
• 76 Zhang J, Shi SY, Peng MJ, Pan J, Wan H, Zhou CS. Simultaneous determination of five active compounds from Dysosma Difformis roots by HPLC. J Liq Chromatogr Relat Technol 2014; 37: 1226-1236
• 77 Renouard S, Corbin C, Colas C, Fidel T, Lopez T, Leclerc EA, Hendrawati O, Falguières A, Doussot J, Ferroud C, Maunit B, Lainé E, Hano C. Aerial parts of Callitris species as a rich source of deoxypodophyllotoxin. Ind Crops Prod 2015; 63: 53-57
• 78 Doussot J, Mathieu V, Colas C, Molinié R, Corbin C, Montguillon J, Banuls LMY, Renouard S, Lamblin F, Dupré P, Maunit B, Kiss R, Hano C, Lainé E. Investigation of the lignan content in extracts from Linum, Callitris and Juniperus species in relation to their in vitro antiproliferative activities. Planta Med 2017; 234: 574-581
• 79 Alam A, Gulati P, Gulati AK, Mishra GP, Naik PK. Assessment of genetic diversity among Podophyllum hexandrum genotypes of the North-western Himalayan region for podophyllotoxin production. Indian J Biotechnol 2009; 8: 391-399
• 80 Zheljazkov V, Cantrell C, Astatkie T. Variation in podophyllotoxin concentration in leaves and rhizomes of American mayapple (Podophyllum peltatum L.). Ind Crops Prod 2011; 33: 633-637
• 81 Mohammad N, Palni L, Kumar A, Nandi S. Podophyllotoxin content, above- and belowground biomass in relation to altitude in Podophyllum hexandrum populations from Kumaun region of the Indian central Himalaya. Planta Med 2007; 73: 388-391
• 82 Kadkade PG. Formation of podophyllotoxins by Podophyllum peltatum tissue cultures. Naturwissenschaften 1981; 68: 481-482
• 83 Heyenga AG, Lucas JA, Dewick PM. Production of tumour-inhibitory lignans in callus cultures of Podophyllum hexandrum . Plant Cell Rep 1990; 9: 382-385
• 84 Woerdenbag HJ, van Uden W, Frijlink HW, Lerk CF, Pras N, Malingré TM. Increased podophyllotoxin production in Podophyllum hexandrum cell suspension cultures after feeding coniferyl alcohol as a β-cyclodextrin complex. Plant Cell Rep 1990; 9: 97-100
• 85 Fujii Y. In vitro regeneration and the production of podophyllotoxins. In: Bajaj YPS, editor Medicinal and Aromatic Plants III. Berlin, Heidelberg: Springer; 1991: 362-375
• 86 Smollny T, Wichers H, Kalenberg S, Shahsavari A, Petersen M, Alfermann AW. Accumulation of podophyllotoxin and related lignans in cell suspension cultures of Linum album . Phytochemistry 1998; 48: 975-979
• 87 Moraes-Cerdeira RM, Burandt CL, Bastos JK, Nanayakkara NP, McChesney JD. In vitro propagation of Podophyllum peltatum . Planta Med 1998; 64: 42-45
• 88 Sharma TR, Singh BM, Sharma NR, Chauhan RS. Identification of high podophyllotoxin producing biotypes of Podophyllum hexandrum Royle from North-Western Himalaya. J Plant Biochem Biotechnol 2000; 9: 49-51
• 89 Chattopadhyay S, Srivastava AK, Bhojwani SS, Bisaria VS. Development of suspension culture of Podophyllum hexandrum for production of podophyllotoxin. Biotechnol Lett 2001; 23: 2063-2066
• 90 Chattopadhyay S, Srivastava AK, Bhojwani SS, Bisaria VS. Production of podophyllotoxin by plant cell cultures of Podophyllum hexandrum in bioreactor. J Biosci Bioeng 2002; 93: 215-220
• 91 Chattopadhyay S, Bisaria VS, Bhojwani SS, Srivastava AK. Enhanced production of podophyllotoxin by fed-batch cultivation of Podophyllum hexandrum . Can J Chem Eng 2003; 81: 1011-1018
• 92 Premjet D, Tachibana S. Production of podophyllotoxin by immobilized cell cultures of Juniperus chinensis . Pak J Biol Sci 2004; 7: 1130-1134
• 93 Shams-Ardakani M, Hemmati S, Mohagheghzadeh A. Effect of elicitors on the enhancement of podophyllotoxin biosynthesis in suspension cultures of Linum album . Daru 2005; 13: 56-60
• 94 Ahmad R, Sharma VK, Rai AK, Shivananda RD, Shivananda BG. Production of lignans in callus culture of Podophyllum hexandrum . Trop J Pharm Res 2007; 6: 803-808
• 95 Anbazhagan V, Ahn C, Harada E, Kim YS, Choi YE. Podophyllotoxin production via cell adventitious root cultures of Podophyllum peltatum . Vitro Cell Dev Biol – Plant 2008; 44: 494-501
• 96 Li W, Li MF, Yang DL, Xu R, Zhang YR. Production podophyllotoxin by root culture of Podophyllum hexandrum Royle. Electron J Biol 2009; 5: 34-39
• 97 Chakraborty A, Bhattacharya D, Ghanta S, Chattopadhyay S. An efficient protocol for in vitro regeneration of Podophyllum hexandrum, a critically endangered medicinal plant. Indian J Biotechnol 2010; 9: 217-220
• 98 Velóz RA, Cardoso-Taketa A, Villarreal ML. Production of podophyllotoxin from roots and plantlets of Hyptis suaveolens cultivated in vitro. Pharmacogn Res 2013; 5: 93-102
• 99 Fakhari S, Sharifi M, Yousefzadi M, Beshamgan E. Effect of some phytohormones on podophyllotoxin production in cell and plantlets cultures of Linum album . J Med Plants-Prod 2013; 2: 83-89
• 100 Samadi A, Jafari M, Nejhad NM, Hossenian F. Podophyllotoxin and 6-methoxy podophyllotoxin production in hairy root cultures of Liunm mucronatum ssp. mucronatum . Pharmacogn Mag 2014; 10: 154-160
• 101 Bamfarahnak H, Gholami A, Bakzadeh Z, Hamedi A. Evaluation of thermal-stress on the accumulation of podophyllotoxin in shoot in vitro cultures of Linum persicum . Res J Pharmacogn 2014; 1: 3-9
• 102 Kašparová M, Martin J, Tůmová L, Spilková J. Production of podophyllotoxin by plant tissue cultures of Juniperus virginiana . Nat Prod Commun 2017; 12: 101-103
• 103 Kašparová M, Pilařová P, Tůmová L, Siatka T. Effect of precursor and phytohormones on podophyllotoxin production in Juniperus virginiana suspension cultures. Nat Prod Commun 2018; 13: 1527-1529
• 104 Karuppaiya P, Tsay HS. Enhanced production of podophyllotoxin, kaempferol, and quercetin from callus culture of Dysosma pleiantha (Hance) Woodson: An endangered medicinal plant. Biotechnol Appl Biochem 2020; 67: 95-104
• 105 Kharkwal AC, Kushwaha R, Prakash O, Ogra RK, Bhattacharya A, Nagar PK, Ahuja PS. An efficient method of propagation of Podophyllum hexandrum: an endangered medicinal plant of the Western Himalayas under ex situ conditions. J Nat Med 2008; 62: 211-216
• 106 Sreenivasulu Y, Chanda SK, Ahuja PS. Endosperm delays seed germination in Podophyllum hexandrum Royle – An important medicinal herb. Seed Sci Technol 2009; 37: 10-16
• 107 Cheng-De LI, Wei LI, Meng-Fei LI, Ping SUN, Wang-Tian W, Yuan-Yuan S. Seed dormancy and germination in endangered plant Podophyllum hexandrum Royle. Bull Bot Res 2008; 28: 618-621
• 108 Jiu X, Chen H, Du T, Jia XW, Liu D, Meng JJ, Xu X. Dormancy release of seeds of Podophyllum hexandrum Royle accompanied by changes in phytochemicals and inorganic elements. PloS One 2023; 18: e0294673
• 109 Kharkwal AC, Prakash O, Bhattacharya A, Nagar PK, Ahuja PS. Method for inducing improved seed germination in Podophyllum hexandrum Royle. US Patent 6449899B1, 2002
• 110 Sharma R, Sharma S, Sharma SS. Seed germination behaviour of some medicinal plants of Lahaul and Spiti cold desert (Himachal Pradesh): Implications for conservation and cultivation. Curr Sci 2006; 90: 1113-1118
• 111 Sharma R, Sharma S, Sharma S. Storage-dependent changes in dormancy and germination of Himalayan Mayapple (Podophyllum hexandrum Royle) seeds and their response to gibberellic acid. J Herbs Spices Med Plants 2010; 16: 69-82
• 112 Simonnet X, Quennoz M, Sigg S, Carlen C. Seed germination behaviour of the endangered medicinal plant Podophyllum hexandrum . Acta Hortic 2012; 955: 309-313
• 113 Singh A, Purohit AN, Bhadula SK, Lata H, Kuniyal C, Chandra S. Seed production potential and germination behaviour in populations of Podophyllum hexandrum Royle. J Plant Biol 1999; 26: 51-58
• 114 Verma N, Verma A, Kumar D. Effect of storage containers on seed germination and viability in Aconitum heterophyllum and Podophyllum hexandrum – endangered medicinal plants species of Himalayan region. Biol Forum 2009; 1: 8-11
• 115 Rust RW, Roth RR. Seed production and seedling establishment in the Mayapple, Podophyllum peltatum L. Am Midl Nat 1981; 105: 51-60
• 116 Moraes R, Lata H, Bedir E, Maqbool M, Cushman K, Janick J, Whipkey A. The American Mayapple and its potential for podophyllotoxin production. In: J Janick, A Whipkey. editors Trends in New Crops and New Uses. Alexandria: ASHS Press; 2002: 527-532
• 117 Cushman K, Maqbool M. Propagule type and planting time affect subsequent growth of American Mayapple. HortScience 2004; 39: 779
• 118 Maqbool M, Cushman KE, Moraes RM, Gerard PD. Overcoming dormancy of Mayapple rhizome segments with low temperature exposure. HortScience 2004; 39: 307-311
• 119 Arumugam N, Bhojwani S. Somatic embryogenesis in tissue cultures of Podophyllum hexandrum . Can J Bot 2011; 68: 487-491
• 120 van Uden W, Pras N, Visser JF, Malingré TM. Detection and identification of podophyllotoxin produced by cell cultures derived from Podophyllum hexandrum royle. Plant Cell Rep 1989; 8: 165-168
• 121 Bisht SS, Bisht S, Nautiyal BP. Development of callus biomass in medicinally important plant Podophyllum hexandrum (Royle) through micro-propagation technology. Int J Curr Res Biosci Plant Biol 2014; 1: 46-50
• 122 Guo Q, Zhou J, Wang Z, Yang H. In vitro rooting of Podophyllum hexandrum and transplanting technique. Engineering 2012; 4: 142-145
• 123 Kim YS, Lim S, Choi YE, Anbazhagan V. High frequency plant regeneration via somatic embryogenesis in Podophyllum peltatum L., an important source of anticancer drug. Curr Sci 2007; 92: 662-666
• 124 Sadowska A, Wiweger M, Łata B, Obidoska G. In vitro propagation of Podophyllum peltatum L. by the cultures of embrya and divided embrya. Biol Plant 1997; 39: 331-336
• 125 Anrini M, Jha S. Characterization of podophyllotoxin yielding cell lines of Podophyllum hexandrum . Caryologia 2009; 62: 220-235
• 126 Sultan P, Shawl A, Ramteke P, Arif J, Nahida C, Neelofar J, Shabir S. In vitro propagation for mass multiplication of Podophyllum hexandrum: A high value medicinal herb. Asian J Plant Sci 2006; 5: 179-184
• 127 Yang X, Guo S, Zhang L, Shao H. Select of producing podophyllotoxin endophytic fungi from podophyllin plan. Nat Prod Res Dev 2003; 15: 419-422
• 128 Eyberger AL, Dondapati R, Porter JR. Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin. J Nat Prod 2006; 69: 1121-1214
• 129 Huang JX, Zhang J, Zhang XR, Zhang K, Zhang X, He XR. Mucor fragilis as a novel source of the key pharmaceutical agents podophyllotoxin and kaempferol. Pharm Biol 2014; 52: 1237-1243
• 130 Kour A, Shawl AS, Rehman S, Sultan P, Qazi PH, Suden P, Khajuria RK, Verma V. Isolation and identification of an endophytic strain of Fusarium oxysporum producing podophyllotoxin from Juniperus recurva . World J Microbiol Biotechnol 2008; 24: 1115-1121
• 131 Nadeem M. Fusarium solani, P1, a new endophytic podophyllotoxin-producing fungus from roots of Podophyllum hexandrum . Afr J Microbiol Res 2012; 6: 2493-2499
• 132 Puri SC, Nazir A, Chawla R, Arora R, Riyaz-ul-Hasan S, Amna T, Ahmed B, Verma V, Singh S, Sagar R, Sharma A, Kumar R, Sharma RK, Qazi GN. The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans. J Biotechnol 2006; 122: 494-510
• 133 Kusari S, Lamshöft M, Zühlke S, Spiteller M. An endophytic fungus from Hypericum perforatum that produces hypericin. J Nat Prod 2008; 71: 159-162
• 134 Mohana Kumara P, Zuehlke S, Priti V, Ramesha BT, Shweta S, Ravikanth G, Vasudeva R, Santhoshkumar TR, Spiteller M, Uma Shaanker R. Fusarium proliferatum, an endophytic fungus from Dysoxylum binectariferum Hook.f, produces rohitukine, a chromane alkaloid possessing anti-cancer activity. Antonie Van Leeuwenhoek 2012; 101: 323-329
• 135 Shweta S, Zuehlke S, Ramesha BT, Priti V, Mohana Kumar P, Ravikanth G, Spiteller M, Vasudeva R, Uma Shaanker R. Endophytic fungal strains of Fusarium solani, from Apodytes dimidiata E. Mey. ex Arn (Icacinaceae) produce camptothecin, 10-hydroxycamptothecin and 9-methoxycamptothecin. Phytochemistry 2010; 71: 117-122
• 136 Zhou X, Zhu H, Liu L, Lin J, Tang K. A review: Recent advances and future prospects of taxol-producing endophytic fungi. Appl Microbiol Biotechnol 2010; 86: 1707-1717
• 137 Cao L, Huang J, Li J. Fermentation conditions of Sinopodophyllum hexandrum endophytic fungus on production of podophyllotoxin. Food Ferment Indust 2007; 33: 28
• 138 Kusari S, Lamshöft M, Spiteller M. Aspergillus fumigatus Fresenius, an endophytic fungus from Juniperus communis L. Horstmann as a novel source of the anticancer pro-drug deoxypodophyllotoxin. J Appl Microbiol 2009; 107: 1019-1030
• 139 Liang Z, Zhang J, Zhang X, Li J, Zhang X, Zhao C. Endophytic fungus from Sinopodophyllum emodi (Wall.) Ying that produces podophyllotoxin. J Chromatogr Sci 2015; 54: 175-178
• 140 Arneaud SLB, Porter JR. Investigation and expression of the Secoisolariciresinol Dehydrogenase gene involved in podophyllotoxin biosynthesis. Mol Biotechnol 2015; 57: 961-973
• 141 Wang T, Ma YX, Ye YH, Zheng HM, Zhang BW, Zhang EH. Screening and molecular identification of podophyllotoxin-producing endophytic fungi from root of endangered Sinopodophyllum hexandrum . Acta Agric Univ Jiangxiensis 2017; 39: 402-408
• 142 Tan XM, Zhou YQ, Zhou XL, Xia XH, Wei Y, He LL, Tang H, Yu L. Diversity and bioactive potential of culturable fungal endophytes of Dysosma versipellis; a rare medicinal plant endemic to China. Sci Rep 2018; 8: 5929
• 143 Nguyen GT, Nguyen HTH, Tran HT, Tran HT, Ho AN, Tran QH, Pham NB. Enhanced podophyllotoxin production of endophyte Fusarium proliferatum TQN5 T by host extract and phenylalanine. Appl Microbiol Biotechnol 2023; 107: 5367-5378
• 144 Naik S, Manjunatha B, Patel M, Ravikanth G, Singh S, Suryanarayanan T, Ganeshaiah KN, Shaanker R. Do endophytic fungi possess pathway genes for plant secondary metabolites?. Curr Sci 2013; 104: 178-182
• 145 Mousa W, Raizada M. The diversity of anti-microbial secondary metabolites produced by fungal endophytes: An interdisciplinary perspective. Front Microbiol 2013; 4: 1-18
• 146 Baldi A, Srivastava AK, Bisaria VS. Improved podophyllotoxin production by transformed cultures of Linum album . Biotechnol J 2008; 3: 1256-1263
• 147 Giri A, Giri CC, Dhingra V, Narasu ML. Enhanced podophyllotoxin production from Agrobacterium rhizogenes transformed cultures of Podophyllum hexandrum . Nat Prod Lett 2001; 15: 229-235
• 148 Unsin CEM, Rajski SR, Shen B. The role of genetic engineering in natural product-based anticancer drug discovery. In: Koehn FE, editor Natural Products and Cancer Drug Discovery. New York: Springer; 2013: 175-191
• 149 Kayser O, Julsing MK, Vasilev NP, Schneidman-Duhovny D, Koulman A, Clarkson C, Woerdenbag HJ, Ionkova I, Wolfson HJ, Bos R, Muntendam R, Jaroszewski JW, Quax WJ. Bioconversion of deoxypodophyllotoxin into epipodophyllotoxin in E. coli using human cytochrome P450 3A4. Planta Med 2008; 74: SL74
• 150 Decembrino D, Ricklefs E, Wohlgemuth S, Girhard M, Schullehner K, Jach G, Urlacher VB. Assembly of plant enzymes in E. Coli for the production of the valuable (−)-podophyllotoxin precursor (−)-pluviatolide. ACS Synth Biol 2020; 9: 3091-3103
• 151 Yousefzadi M, Sharifi M, Behmanesh M, Ghasempour A, Moyano E, Palazon J. The effect of light on gene expression and podophyllotoxin biosynthesis in Linum album cell culture. Plant Physiol Biochem 2012; 56: 41-46
• 152 Lv M, Su HY, Li ML, Yang DL, Yao RY, Li MF, Wei JH. Effect of UV-B radiation on growth, flavonoid and podophyllotoxin accumulation, and related gene expression in Sinopodophyllum hexandrum . Plant Biol Stuttg Ger 2021; 23: 202-209
• 153 van Uden W, Pras N, Malingré TM. On the improvement of the podophyllotoxin production by phenylpropanoid precursor feeding to cell cultures of Podophyllum hexandrum Royle. Plant Cell Tissue Organ Cult 1990; 23: 217-224
• 154 Alam MA, Naik PK. Impact of soil nutrients and environmental factors on podophyllotoxin content among 28 Podophyllum hexandrum populations of northwestern Himalayan region using linear and nonlinear approaches. Commun Soil Sci Plant Anal 2009; 40: 2485-2504
• 155 Li MF, Li W, Yang DL, Zhou LL, Li TT, Su XM. Relationship between podophyllotoxin accumulation and soil nutrients and the influence of Fe²⁺ and Mn²⁺ on podophyllotoxin biosynthesis in Podophyllum hexandrum tissue culture. Plant Physiol Biochem 2013; 71: 96-102
• 156 Seegers CLC, Setroikromo R, Tepper PG, Horvatovich P, Peters R, Quax WJ. Methyl jasmonate treatment increases podophyllotoxin production in Podophyllum hexandrum roots under glasshouse conditions. Plant Soil 2017; 417: 117-126
• 157 Yang DL, Sun P, Li MF. Chilling temperature stimulates growth, gene over-expression and podophyllotoxin biosynthesis in Podophyllum hexandrum Royle. Plant Physiol Biochem 2016; 107: 197-203
• 158 Palaniyandi K, Jun W. Low temperature enhanced the podophyllotoxin accumulation vis-a-vis its biosynthetic pathway gene(s) expression in Dysosma versipellis (Hance) M. Cheng – A pharmaceutically important medicinal plant. Process Biochem 2020; 95: 197-203
• 159 Kushwaha R, Bhattacharya A, Singh B, Singh RD. Factors affecting podophyllotoxin yield in the ex situ grown Podophyllum hexandrum, an endangered alpine native of the Western Himalayas. J Nat Med 2012; 66: 1-7
• 160 Chattopadhyay S, Mehra RS, Srivastava AK, Bhojwani SS, Bisaria VS. Effect of major nutrients on podophyllotoxin production in Podophyllum hexandrum suspension cultures. Appl Microbiol Biotechnol 2003; 60: 541-546
• 161 Li M, Ge L, Kang T, Sun P, Xing H, Yang D, Zhang J, Paré PW. High-elevation cultivation increases anti-cancer podophyllotoxin accumulation in Podophyllum hexandrum . Ind Crops Prod 2018; 121: 338-344
• 162 Rajesh M, Sivanandhan G, Arun M, Vasudevan V, Theboral J, Girija S, Manickavasagam M, Selvaraj N, Ganapathi A. Factors influencing podophyllotoxin production in adventitious root culture of Podophyllum hexandrum Royle. Acta Physiol Plant 2014; 36: 1009-1021
• 163 Meira PR, David JP, de O Ribeiro EM, Santana JRF, Brandão HN, de Oliveira LM, David JM, Medrado HH, Pastore JFB. Abiotic factors influencing podophyllotoxin and yatein overproduction in Leptohyptis macrostachys cultivated in vitro. Phytochem Lett 2017; 22: 287-292
• 164 Rao SR, Ravishankar GA. Plant cell cultures: Chemical factories of secondary metabolites. Biotechnol Adv 2002; 20: 101-153
• 165 Zhao J, Davis LC, Verpoorte R. Elicitor signal transduction leading to production of plant secondary metabolites. Biotechnol Adv 2005; 23: 283-333
• 166 Baldi A, Farkya S, Jain A, Gupta N, Mehra R, Datta V, Srivastava AK, Bisaria VS. Enhanced production of podophyllotoxins by co-culture of transformed Linum album cells with plant growth-promoting fungi. Pure Appl Chem 2010; 82: 227-241
• 167 Kumar P, Sharma R, Jaiswal V, Chauhan RS. Identification, validation, and expression of ABC transporters in Podophyllum hexandrum and their role in podophyllotoxin biosynthesis. Biol Plant 2016; 60: 452-458
• 168 Nag A, Choudhary S, Masand M, Parmar R, Bhandawat A, Seth R, Singh G, Dhyani P, Sharma RK. Spatial transcriptional dynamics of geographically separated genotypes revealed key regulators of podophyllotoxin biosynthesis in Podophyllum hexandrum . Ind Crops Prod 2020; 147: 112247
• 169 Javadian N, Karimzadeh G, Sharifi M, Moieni A, Behmanesh M. In vitro polyploidy induction: Changes in morphology, podophyllotoxin biosynthesis, and expression of the related genes in Linum album (Linaceae). Planta 2017; 245: 1165-1178
• 170 Hazra S, Bhattacharyya D, Chattopadhyay S. Methyl jasmonate regulates podophyllotoxin accumulation in Podophyllum hexandrum by altering the ROS-responsive podophyllotoxin pathway gene expression additionally through the down regulation of few interfering miRNAs. Front Plant Sci 2017; 8: 1-9
• 171 Kumar P, Pal T, Sharma N, Kumar V, Sood H, Chauhan RS. Expression analysis of biosynthetic pathway genes vis-à-vis podophyllotoxin content in Podophyllum hexandrum Royle. Protoplasma 2015; 252: 1253-1262
• 172 Kumar P, Jaiswal V, Pal T, Singh J, Chauhan RS. Comparative whole-transcriptome analysis in Podophyllum species identifies key transcription factors contributing to biosynthesis of podophyllotoxin in P. hexandrum . Protoplasma 2017; 254: 217-228
• 173 Bhattacharyya D, Sinha R, Hazra S, Datta R, Chattopadhyay S. De novo transcriptome analysis using 454 pyrosequencing of the Himalayan Mayapple, Podophyllum hexandrum . BMC Genomics 2013; 14: 748
• 174 Vasilev NP, Julsing MK, Koulman A, Clarkson C, Woerdenbag HJ, Ionkova I, Bos R, Jaroszewski JW, Kayser O, Quax WJ. Bioconversion of deoxypodophyllotoxin into epipodophyllotoxin in E. coli using human cytochrome P450 3A4. J Biotechnol 2006; 126: 383-393
• 175 Teng RW, McManus D, Mau SL, Bacic A. Biotransformation of podophyllotoxin by Hordeum vulgare cell suspension cultures. Biocatal Biotransformation 2007; 25: 1-8
• 176 Loike JD, Horwitz SB. Effects of podophyllotoxin and VP-16–213 on microtubule assembly in vitro and nucleoside transport in HeLa cells. Biochemistry 1976; 15: 5435-5443
• 177 Hu LL, Liao BY, Wei JX, Ling YL, Wei YX, Liu ZL, Luo XQ, Wang JL. Podophyllotoxin exposure causes spindle defects and DNA damage-induced apoptosis in mouse fertilized oocytes and early embryos. Front Cell Dev Biol 2020; 8: 600521
• 178 Sinkule JA. Etoposide: A semisynthetic epipodophyllotoxin chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent. Pharmacotherapy 1984; 4: 61-73
• 179 Imbert TF. Discovery of podophyllotoxins. Biochimie 1998; 80: 207-222
• 180 Wu CC, Li TK, Farh L, Lin LY, Lin TS, Yu YJ, Yen TJ, Chiang CW, Chan NL. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science 2011; 333: 459-462
• 181 Jiang Z, Wu M, Miao J, Duan H, Zhang S, Chen M, Sun L, Wang Y, Zhang X, Zhu X, Zhang L. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects. Int J Biochem Cell Biol 2013; 45: 1710-1719
• 182 Jung CH, Kim H, Ahn J, Jung SK, Um MY, Son KH, Kim TW, Ha TY. Anthricin isolated from Anthriscus sylvestris (L.) Hoffm. inhibits the growth of breast cancer cells by inhibiting Akt/mTOR signaling, and its apoptotic effects are enhanced by autophagy inhibition. Evid-Based Complement Altern Med ECAM 2013; 1: 385219:1-9
• 183 Benzina S, Harquail J, Jean S, Beauregard AP, Colquhoun CD, Carroll M, Bos A, Gray CA, Robichaud GA. Deoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells. Anticancer Agents Med Chem 2015; 15: 79-88
• 184 Wang YR, Xu Y, Jiang ZZ, Guerram M, Wang B, Zhu X, Zhang LY. Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in SGC-7901 cells and inhibits tumor growth in vivo. Molecules 2015; 20: 1661-1675
• 185 Ardalani H, Avan A, Ghayour-Mobarhan M. Podophyllotoxin: A novel potential natural anticancer agent. Avicenna J Phytomedicine 2017; 7: 285-294
• 186 Khazir J, Mir BA, Pilcher L, Riley DL. Role of plants in anticancer drug discovery. Phytochem Lett 2014; 7: 173-181
• 187 Lee CC, Huang TS. A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage. Pharm Res 2001; 18: 846-851
• 188 Hanauske AR, Wüster KC, Lehmer A, Rotter M, Schneider P, Kaeser-Fröhlich A, Rastetter J, Depenbrock H. Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro. Eur J Cancer 1995; 31: 1677-1681
• 189 Utsugi T, Shibata J, Sugimoto Y, Aoyagi K, Wierzba K, Kobunai T, Terada T, Oh-hara T, Tsuruo T, Yamada Y. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Cancer Res 1996; 56: 2809-2814
• 190 Yoshida M, Kobunai T, Aoyagi K, Saito H, Utsugi T, Wierzba K, Yamada Y. Specific distribution of TOP-53 to the lung and lung-localized tumor is determined by its interaction with phospholipids. Clin Cancer Res Off J Am Assoc Cancer Res 2000; 6: 4396-4401
• 191 Cline SD, Macdonald TL, Osheroff N. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine. Biochemistry 1997; 36: 13095-13101
• 192 Leteurtre F, Sackett DL, Madalengoitia J, Kohlhagen G, Macdonald T, Hamel E, Paull KD, Pommier Y. Azatoxin derivatives with potent and selective action on topoisomerase II. Biochem Pharmacol 1995; 49: 1283-1290
• 193 Chen JY, Tang YA, Li WS, Chiou YC, Shieh JM, Wang YC. A synthetic podophyllotoxin derivative exerts anti-cancer effects by inducing mitotic arrest and pro-apoptotic ER stress in lung cancer preclinical models. PLOS ONE 2013; 8: e62082
• 194 Choi JY, Hong WG, Cho JH, Kim EM, Kim J, Jung CH, Hwang SG, Um HD, Park JK. Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy. Int J Oncol 2015; 47: 1257-1265
• 195 Zhao Y, Wu Z, Zhang Y, Zhu L. HY-1 induces G2/M cell cycle arrest in human colon cancer cells through the ATR-Chk1-Cdc25C and Weel pathways. Cancer Sci 2013; 104: 1062-1066
• 196 Zhang L, Wang J, Liu L, Zheng C, Wang Y. Synthesis and antiproliferative activity of novel all-trans-retinoic acid-podophyllotoxin conjugate towards human gastric cancer cells. Molecules 2017; 22: 628
• 197 Sharma S, Mehak. Chhimwal J, Patial V, Sk UH. Dendrimer-conjugated podophyllotoxin suppresses DENA-induced HCC progression by modulation of inflammatory and fibrogenic factors. Toxicol Res 2019; 8: 560-567
• 198 Wang Y, Sun H, Xiao Z, Zhang G, Zhang D, Bao X, Li F, Wu S, Gao Y, Wei N. DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer. Cell Commun Signal 2018; 16: 52
• 199 Wang J, Long L, Chen Y, Xu Y, Zhang L. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents. Bioorg Med Chem Lett 2018; 28: 1817-1824
• 200 Biswas D, Biswas P, Nandy S, Mukherjee A, Pandey DK, Dey A. Endophytes producing podophyllotoxin from Podophyllum sp. and other plants: A review on isolation, extraction and bottlenecks. South Afr J Bot 2020; 134: 303-313
• 201 Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020). Eur J Med Chem 2020; 208: 112830
• 202 Guerrero E, Abad A, Montenegro G, Del Olmo E, López-Pérez JL, San Feliciano A. Analgesic and anti-inflammatory activity of podophyllotoxin derivatives. Pharm Biol 2013; 51: 566-572